Average Co-Inventor Count = 8.25
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (20 from 1,970 patents)
2. Merck Sharp + Dohme Corp. (3 from 2,405 patents)
23 patents:
1. 11279712 - Macrocyclic compounds that inhibit MCL-1 protein
2. 11224601 - Compounds that inhibits MCL-1 protein
3. 10947223 - Substituted oxazines as beta-secretase inhibitors
4. 10889581 - Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
5. 10889579 - Thiazine derivatives as β-secretase inhibitors and methods of use
6. 10821115 - Compounds that inhibit Mcl-1 protein
7. 10632128 - Compounds that inhibit Mcl-1 protein
8. 9611261 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
9. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
10. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
11. 9096559 - 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12. 9085576 - Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
13. 8952037 - Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
14. 8946230 - Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors
15. 8791147 - Calcium receptor modulating agents